“The firm documented that it imported a pure, unformulated active ingredient when it was an advanced preparation,” the agency explained in a statement.
The Customs General Directorate (DGA) fined the pharmaceutical company Pfizer by do not pay import taxes corresponding to almost three tons of a medical preparation to prepare ibuprofenthe component is valued at US$450,000 and the fine he paid the company was US$80,883.20.
“The signature documented that a pure active ingredient was imported without formulating when “It was an advanced preparation.”the organization explained in a statement.
imports-exports-trade-containers-port-customs.jpg
In addition, Customs noted that “The goal was to pay less taxes”, since the preparation has a higher import tariff than the other substance. As explained by Customs, one pays 2% and the other 8%.
Customs: how did you discover the irregular import?
The specialized agents of the agency discovered that the company documented that it imported a pure active ingredient without formulating, what It was confirmed by specialists “that it was not true”.
Then, after a information analysis workcustoms personnel discovered that It was a preparation in an advanced state of formulation with therapeutic characteristics.
Pills.jpg
The substance, valued at US$450,000is used in the production of Ibuprofen that the firm manufactures. In total they were 2,901 kilos of medicinal preparation.
The irregular operation on the part of the Pfizer is typified in the article 954 section A of the Custom codethe statement stated.
In that same sense, according to current regulations, the penalty fee corresponding this between one to five times the tax loss caused what Pfizer acknowledged the fact and paid the violation voluntarily.
Source: Ambito
